Market Value115,489,427
Total Holdings61
File Date2025-06-30
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TXG / 10x Genomics, Inc.
CORT / Corcept Therapeutics Incorporated
TMCI / Treace Medical Concepts, Inc.
ALMS / Alumis Inc.
EQT / EQT Corporation
DCGO / DocGo Inc.
KALV / KalVista Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
CERO THERAPEUTICS HOLDINGS INC / CLASS A COM (71902K105)
KPTI / Karyopharm Therapeutics Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
OM / Outset Medical, Inc.
QDEL / QuidelOrtho Corporation
ZNTL / Zentalis Pharmaceuticals, Inc.
AXDX / Accelerate Diagnostics, Inc.
BDSX / Biodesix, Inc.
ALKS / Alkermes plc
TVTX / Travere Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
AXGN / Axogen, Inc.
CGEM / Cullinan Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
PTGX / Protagonist Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
HROW / Harrow, Inc.
VTYX / Ventyx Biosciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
FOLD / Amicus Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
PGNY / Progyny, Inc.
CHRS / Coherus Oncology, Inc.
KROS / Keros Therapeutics, Inc.
UTHR / United Therapeutics Corporation
CSTL / Castle Biosciences, Inc.
QURE / uniQure N.V.
INBX / Inhibrx Biosciences, Inc.
AXSM / Axsome Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
NVCR / NovoCure Limited
BPMC / Blueprint Medicines Corporation
LQDA / Liquidia Corporation
HALO / Halozyme Therapeutics, Inc.
ELUT / Elutia Inc.
APLS / Apellis Pharmaceuticals, Inc.
TSVT / 2seventy bio, Inc.
OVV / Ovintiv Inc.
WVE / Wave Life Sciences Ltd.
PHR / Phreesia, Inc.
PRTA / Prothena Corporation plc
SWTX / SpringWorks Therapeutics, Inc.
ARVN / Arvinas, Inc.
SRPT / Sarepta Therapeutics, Inc.
XNCR / Xencor, Inc.
IFRX / InflaRx N.V.
ACAD / ACADIA Pharmaceuticals Inc.
BHVN / Biohaven Ltd.
FHTX / Foghorn Therapeutics Inc.
BMY / Bristol-Myers Squibb Company
BCRX / BioCryst Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
MASI / Masimo Corporation